NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000001456

Registered date:01/04/2010

The effect of angiotensin II receptor blocker (ARB) or thiazolidinedione (TZD) on adipocytokines and oxidative stress markers (Senri Study II)

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedHypertensive and/or Diabetic patients
Date of first enrollment2008/08/01
Target sample size200
Countries of recruitmentJapan
Study typeObservational
Intervention(s)

Outcome(s)

Primary OutcomeChanges of TBARS(Thiobarbituric acid reactive substances), highsensitive CRP, and Adiponectin at the completion of treatment form baseline
Secondary OutcomeChanges of waist circumference, glucose-lipid metabolic parameters, and blood pressure

Key inclusion & exclusion criteria

Age minimumNot applicable
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteria1)Contraindications of candesartan 2)Contraindications of Pioglitazone

Related Information

Contact

public contact
Name Ken Kishida
Address Japan
Telephone
E-mail kkishida@imed2.med.osaka-u.ac.jp
Affiliation Osaka University Metabolic medicine
scientific contact
Name Iichiro Shimomura, Tohru Funahashi
Address 2-2 B5, Yamada-oka, Suita, Osaka, 565-0871, Japan Japan
Telephone 06-6879-3732
E-mail
Affiliation Osaka University Metabolic medicine